{
    "nctId": "NCT04920669",
    "briefTitle": "Dexmedetomidine in Erector Spinae Block in Postoperative Analgesia",
    "officialTitle": "Can Dexmedetomidine Improve the Analgesic Duration and Efficacy of Erector Spinae Plane Block in Breast Cancer Surgeries?",
    "overallStatus": "COMPLETED",
    "conditions": "Postoperative Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 58,
    "primaryOutcomeMeasure": "Time to first request of analgesia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Provision of signed and dated informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n* Female, aged (18-70) years\n* Belongs to American Society of Anaesthesiologists physical status class II.\n* Scheduled for breast cancer surgeries.\n\nExclusion Criteria:\n\n* Patient refusal.\n* Local infection at the site of the block.\n* Cardiac dysfunction (ejection fraction \\<45%).\n* Preexisting neurological or psychiatric disease, communication difficulties, inability to use the patient-controlled analgesia (PCA) device.\n* Allergy to one of the study drugs.\n* Pregnancy.\n* Coagulopathy (PC \\<60% and platelet count\\<100.000).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}